Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001193125-26-274305

Chief Executive Officer acquired 7,761 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Weis Holger Chief Executive Officer 2026-06-12 Grant or award +7,761 $2.26 $17,540 12,672 D: show line 1 in the form
Loading xslF345X06/ownership.xml…